NTR vs. BMY
Compare and contrast key facts about Nutrien Ltd. (NTR) and Bristol-Myers Squibb Company (BMY).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: NTR or BMY.
Correlation
The correlation between NTR and BMY is 0.22, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
NTR vs. BMY - Performance Comparison
Key characteristics
NTR:
-0.62
BMY:
0.64
NTR:
-0.78
BMY:
1.21
NTR:
0.91
BMY:
1.15
NTR:
-0.28
BMY:
0.38
NTR:
-1.10
BMY:
1.57
NTR:
14.74%
BMY:
11.56%
NTR:
26.40%
BMY:
28.50%
NTR:
-58.18%
BMY:
-70.62%
NTR:
-57.67%
BMY:
-23.12%
Fundamentals
NTR:
$22.93B
BMY:
$116.92B
NTR:
$1.48
BMY:
-$3.58
NTR:
1.15
BMY:
1.92
NTR:
$31.02B
BMY:
$47.44B
NTR:
$9.09B
BMY:
$33.40B
NTR:
$5.31B
BMY:
$5.06B
Returns By Period
In the year-to-date period, NTR achieves a -18.30% return, which is significantly lower than BMY's 17.38% return.
NTR
-18.30%
-2.85%
-11.67%
-18.05%
1.76%
N/A
BMY
17.38%
-0.95%
40.36%
17.50%
1.50%
2.84%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
NTR vs. BMY - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Nutrien Ltd. (NTR) and Bristol-Myers Squibb Company (BMY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
NTR vs. BMY - Dividend Comparison
NTR's dividend yield for the trailing twelve months is around 4.82%, more than BMY's 4.19% yield.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NTR Nutrien Ltd. | 4.82% | 3.76% | 2.63% | 2.45% | 3.74% | 3.67% | 3.47% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
BMY Bristol-Myers Squibb Company | 4.19% | 4.44% | 3.00% | 2.36% | 3.69% | 2.55% | 3.08% | 2.55% | 1.95% | 2.17% | 2.46% | 3.31% |
Drawdowns
NTR vs. BMY - Drawdown Comparison
The maximum NTR drawdown since its inception was -58.18%, smaller than the maximum BMY drawdown of -70.62%. Use the drawdown chart below to compare losses from any high point for NTR and BMY. For additional features, visit the drawdowns tool.
Volatility
NTR vs. BMY - Volatility Comparison
Nutrien Ltd. (NTR) has a higher volatility of 7.36% compared to Bristol-Myers Squibb Company (BMY) at 6.16%. This indicates that NTR's price experiences larger fluctuations and is considered to be riskier than BMY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
NTR vs. BMY - Financials Comparison
This section allows you to compare key financial metrics between Nutrien Ltd. and Bristol-Myers Squibb Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities